Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study
Open Access
- 21 March 2015
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-11
Abstract
Metastasis of colorectal cancer (CRC) is directly linked to patient survival. We previously identified the novel gene Metastasis Associated in Colon Cancer 1 (MACC1) in CRC and demonstrated its importance as metastasis inducer and prognostic biomarker. Here, we investigate the geographic expression pattern of MACC1 in colorectal adenocarcinoma and tumor buds in correlation with clinicopathological and molecular features for improvement of survival prognosis. We performed geographic MACC1 expression analysis in tumor center, invasive front and tumor buds on whole tissue sections of 187 well-characterized CRCs by immunohistochemistry. MACC1 expression in each geographic zone was analyzed with Mismatch repair (MMR)-status, BRAF/KRAS-mutations and CpG-island methylation. MACC1 was significantly overexpressed in tumor tissue as compared to normal mucosa (p < 0.001). Within colorectal adenocarcinomas, a significant increase of MACC1 from tumor center to front (p = 0.0012) was detected. MACC1 was highly overexpressed in 55% tumor budding cells. Independent of geographic location, MACC1 predicted advanced pT and pN-stages, high grade tumor budding, venous and lymphatic invasion (p < 0.05). High MACC1 expression at the invasive front was decisive for prediction of metastasis (p = 0.0223) and poor survival (p = 0.0217). The geographic pattern of MACC1 did not correlate with MMR-status, BRAF/KRAS-mutations or CpG-island methylation. MACC1 is differentially expressed in CRC. At the invasive front, MACC1 expression predicts best aggressive clinicopathological features, tumor budding, metastasis formation and poor survival outcome.Keywords
This publication has 46 references indexed in Scilit:
- Metastasis-Associated in Colon Cancer 1 Is a Novel Survival-Related Biomarker for Human Patients with Renal Pelvis CarcinomaPLOS ONE, 2014
- MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathwayOncotarget, 2014
- MET Signaling in Colon Cancer Stem-like Cells Blunts the Therapeutic Response to EGFR InhibitorsCancer Research, 2014
- MACC1 overexpression predicts a poor prognosis for non-small cell lung cancerMedical Oncology, 2013
- Integrative Marker Analysis Allows Risk Assessment for Metastasis in Stage II Colon CancerAnnals of Surgery, 2012
- Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis.2011
- Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotargetOncotarget, 2010
- Her2-Diagnostik beim MagenkarzinomDer Pathologe, 2010
- Genome-wide expression patterns of invasion front, inner tumor mass and surrounding normal epithelium of colorectal tumorsMolecular Cancer, 2007
- What's wrong with Bonferroni adjustmentsBMJ, 1998